STEM
Conflict-of-Interest Restrictions Needed to Ensure Strong FDA review
A 2012 law that loosened conflict-of-interest restrictions for FDA advisory panels could weaken the agency's review system and could allow more drugs with safety problems to gain market approval, says a new analysis published June 7 in Science by researchers at the George Washington University School of Public Health and Health Services (SPHHS).
Facebook: A Confidence Boost for First-Gen College Students
Mars Rover Opportunity Finds Evidence of Water on the Red Planet
Clinical Sequencing Technology Identifies New Targets in Diverse Cancers
Lizard King: Extinct 60-Pound Reptile Named After Jim Morrison
Steroid Injection Therapy May Increase Risk of Spinal Fracture
NASA Curiosity Mars Rover to Travel to Mysterious Mount Sharp
'Belief in Science' Increases in Stressful Situations
By Staff ReporterColorado Researchers Discover Significantly Lower Levels of Air Pollution in Los Angeles
By Russell WesterholmObese Patients Trust Diet Advice from Overweight Physicians More than Normal-Weight Physicians
By Staff ReporterStorm Chaser Tim Samaras Dies; His Last Tornado Footage Released (VIDEO)
By Staff ReporterNew Study at the University of Kentucky Finds Horses Help People Develop Social Skills
By Russell WesterholmMathematical Models to Better Combat HIV
By Staff ReporterGlobal Warming Caused by CFCs, Not Carbon Dioxide, Study Says
By Staff ReporterResearchers Hope to Use New Brain Imaging Technique to Better Understand Alzheimer's
By Russell Westerholm
